Back to list

Insulin detemir in the management of type 2 diabetes in non-Western countries: Safety and effectiveness data from the A1chieve observational study

Alexey Zilov, Nabil El Naggar, Siddharth Shah, Chunduo Shen and Jihad Haddad

Diabetes Research and Clinical Practice, 3, 101, pages 317 - 325

Received 24 December 2012, Revised 16 May 2013, Accepted 6 June 2013, Published online Oct-2013


Article view:

Authors

Alexey Zilov a lowast , Nabil El Naggar b, Siddharth Shah c, Chunduo Shen d and Jihad Haddad e

Footnotes

a Department of Endocrinology, First Moscow State Medical University, Moscow, Russia

b Internal Medicine, Hai Aljamea Hospital, Jeddah, The Kingdom of Saudi Arabia

c Bhatia Hospital, Mumbai, India

d Novo Nordisk International Operations, Zurich Switzerland

e Division of Endocrinology, Prince Hamazah Hospital, Amman, Jordan

lowast Corresponding author. MD PhD, Department of Endocrinology, First Moscow State Medical University, 1 Pogodinskaya Street, Office 622, Moscow, Russia. Tel.: +7 9037180050.

This study was funded by Novo Nordisk.

☆☆ Clinical trial registration: Clinicaltrials.gov, NCT00869908.


Back to list